Lonza to Acquire Five US CDMO Sites from Merck KGaA

• November 11, 2026

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

• by Assistant Secretary for Public Affairs (ASPA)

• November 5, 2026

Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study

• by Elizabeth K. O’Donnell, Omar Nadeem, Jacob P. Laubach, Giada Bianchi, Andrew R. Branagan, Brea C. Lipe, Paul G. Richardson, Ehsan Malek, Robb S. Friedman, Ajay K. Nooka, Robert Redd, Noopur S. Raje, Andrew J. Yee

• November 2, 2026

Video: The Ultimate in Translational Medicine – with Harold Keer

Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes

• November 6, 2026

• 1 min